AiON

Severe alopecia areata in adolescents

Severe alopecia areata in patients aged 12 to under 18. In Spain, baricitinib is indicated from the age of 12 (4 mg daily for those weighing 30 kg or more), according to the current summary of product characteristics. The Spanish National Health System funding approved in 2023 applies to adults only.

Institutional endorsement by Clínica Evolution

This entry is for information. Your case requires an individual medical assessment.